OTCMKTS:AVDX - Avant Diagnostics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.03 0.00 (0.00 %)
(As of 01/17/2019 12:01 PM ET)
Previous Close$0.0250
Today's Range$0.0113 - $0.03
52-Week Range$0.0001 - $0.0784
Volume20,100 shs
Average Volume2,028 shs
Market Capitalization$8.42 million
P/E RatioN/A
Dividend YieldN/A
Avant Diagnostics, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary diagnostic tests that provide information for physicians and patients in the areas of cancers. It offers OvaDx, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer. The company was founded in 2009 and is based in Washington, District of Columbia.

Receive AVDX News and Ratings via Email

Sign-up to receive the latest news and ratings for AVDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous equipment rental & leasing
Current SymbolOTCMKTS:AVDX


Current RatioN/A
Quick RatioN/A


Sales & Book Value

Annual Sales$250,000.00
Price / Sales40.44
Price / Cash FlowN/A
Price / BookN/A


Net IncomeN/A
Net MarginsN/A
Return on AssetsN/A


Market Cap$8.42 million
OptionableNot Optionable

Avant Diagnostics (OTCMKTS:AVDX) Frequently Asked Questions

What is Avant Diagnostics' stock symbol?

Avant Diagnostics trades on the OTCMKTS under the ticker symbol "AVDX."

Has Avant Diagnostics been receiving favorable news coverage?

Media coverage about AVDX stock has been trending positive this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avant Diagnostics earned a daily sentiment score of 2.6 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the stock's share price in the next few days.

Who are some of Avant Diagnostics' key competitors?

Who are Avant Diagnostics' key executives?

Avant Diagnostics' management team includes the folowing people:
  • Mr. Jeffrey M. Busch, Exec. Chairman (Age 58)
  • Dr. Michael I. Ruxin, Pres, CEO & Director (Age 72)
  • Mr. Scott VanderMeer, Interim Chief Financial Officer (Age 32)
  • Dr. Glenn D. Hoke Ph.D., Chief Scientific Officer
  • Ms. Rene A. Schena, Chairman & CEO of Arrayit Corp. (Age 55)

How do I buy shares of Avant Diagnostics?

Shares of AVDX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Avant Diagnostics' stock price today?

One share of AVDX stock can currently be purchased for approximately $0.03.

How big of a company is Avant Diagnostics?

Avant Diagnostics has a market capitalization of $8.42 million and generates $250,000.00 in revenue each year. Avant Diagnostics employs 1 workers across the globe.

What is Avant Diagnostics' official website?

The official website for Avant Diagnostics is http://www.avantdiagnostics.com.

How can I contact Avant Diagnostics?

Avant Diagnostics' mailing address is 1050 30TH STREET NW SUITE 107, WASHINGTON DC, 20007. The company can be reached via phone at 708-710-9200 or via email at [email protected]

MarketBeat Community Rating for Avant Diagnostics (OTCMKTS AVDX)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  31 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  73
MarketBeat's community ratings are surveys of what our community members think about Avant Diagnostics and other stocks. Vote "Outperform" if you believe AVDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Featured Article: Quiet Period

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel